Cefalu WT - Search Results

1

An update on sodium-glucose co-transporter-2 inhibitors for the treatment of diabetes mellitus.

Hsia DS, Grove O, Cefalu WT. Hsia DS, et al. Among authors: cefalu wt. Curr Opin Endocrinol Diabetes Obes. 2017 Feb;24(1):73-79. doi: 10.1097/MED.0000000000000311. Curr Opin Endocrinol Diabetes Obes. 2017. PMID: 27898586 Free PMC article. Review.

2

Paradoxical insights into whole body metabolic adaptations following SGLT2 inhibition.

Cefalu WT. Cefalu WT. J Clin Invest. 2014 Feb;124(2):485-7. doi: 10.1172/JCI74297. Epub 2014 Jan 27. J Clin Invest. 2014. PMID: 24463446 Free PMC article.

3

Validity of serum fructosamine as index of short-term glycemic control in diabetic outpatients.

Cefalu WT, Parker TB, Johnson CR. Cefalu WT, et al. Diabetes Care. 1988 Sep;11(8):662-4. doi: 10.2337/diacare.11.8.662. Diabetes Care. 1988. PMID: 3219971 No abstract available.

4

Total serum glycosylated proteins in detection and monitoring of gestational diabetes.

Cefalu WT, Prather KL, Chester DL, Wheeler CJ, Biswas M, Pernoll ML. Cefalu WT, et al. Diabetes Care. 1990 Aug;13(8):872-5. doi: 10.2337/diacare.13.8.872. Diabetes Care. 1990. PMID: 2209322

5

Efficacy and safety of canagliflozin monotherapy in subjects with type 2 diabetes mellitus inadequately controlled with diet and exercise.

Stenlöf K, Cefalu WT, Kim KA, Alba M, Usiskin K, Tong C, Canovatchel W, Meininger G. Stenlöf K, et al. Among authors: cefalu wt. Diabetes Obes Metab. 2013 Apr;15(4):372-82. doi: 10.1111/dom.12054. Epub 2013 Jan 24. Diabetes Obes Metab. 2013. PMID: 23279307 Free PMC article. Clinical Trial.

6

Long-term maintenance of efficacy of dapagliflozin in patients with type 2 diabetes mellitus and cardiovascular disease.

Leiter LA, Cefalu WT, de Bruin TW, Xu J, Parikh S, Johnsson E, Gause-Nilsson I. Leiter LA, et al. Among authors: cefalu wt. Diabetes Obes Metab. 2016 Aug;18(8):766-74. doi: 10.1111/dom.12666. Epub 2016 May 12. Diabetes Obes Metab. 2016. PMID: 27009868

7

Inverse correlation of serum inflammatory markers with metabolic parameters in healthy, Black and White prepubertal youth.

Zabaleta J, Velasco-Gonzalez C, Estrada J, Ravussin E, Pelligrino N, Mohler MC, Larson-Meyer E, Boulares AH, Powell-Young Y, Bennett B, Happel K, Cefalu W, Scribner R, Tseng TS, Sothern M. Zabaleta J, et al. Int J Obes (Lond). 2014 Apr;38(4):563-8. doi: 10.1038/ijo.2013.220. Epub 2013 Nov 26. Int J Obes (Lond). 2014. PMID: 24276016 Free PMC article.

8

Extramyocellular adipose tissue in type 2 diabetes.

Luu L, Crilly J, Newcomer B, Cefalu W. Luu L, et al. Can J Diabetes. 2009;33(3):303. doi: 10.1016/S1499-2671(09)33297-9. Epub 2012 Dec 10. Can J Diabetes. 2009. PMID: 25998601 No abstract available.

9

Inflammation, insulin resistance, and type 2 diabetes: back to the future?

Cefalu WT. Cefalu WT. Diabetes. 2009 Feb;58(2):307-8. doi: 10.2337/db08-1656. Diabetes. 2009. PMID: 19171748 Free PMC article. No abstract available.

10

Psychosocial Research and Care in Diabetes: Altering Lives by Understanding Attitudes.

Weinger K, de Groot M, Cefalu WT. Weinger K, et al. Among authors: cefalu wt. Diabetes Care. 2016 Dec;39(12):2122-2125. doi: 10.2337/dc16-2056. Diabetes Care. 2016. PMID: 27879357 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results